Fleury S.A. (FLRY3.SA) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Services · Brazil · ISIN BRFLRYACNOR5

Price
27.82 BRL
Market cap
15.16 bn BRL
P/E (2025)
24.74
P/S (2025)
1.83
Dividend yield
4.67 %
Net margin
7.39 %
Return on equity (ROE)
12.25 %
Return on assets (ROA)
4.64 %

Fleury S.A. financials

Fiscal year20242025
Revenue7.68 bn BRL8.29 bn BRL
Gross profit2.14 bn BRL1.99 bn BRL
Operating income1.20 bn BRL1.22 bn BRL
EBIT1.32 bn BRL1.22 bn BRL
Net income616.17 m BRL612.83 m BRL
Diluted EPS – continuing operations1.13 BRL1.12 BRL

Full history since 2006, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Fleury S.A.

Fleury S.A., together with its subsidiaries, engages in the provision of diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides medical services in the areas of diagnostics, laboratory support, infusions, clinical analyses, health management, healthcare, assistance medicine, orthopedics, ophthalmology, toxicological tests, fertility, infusions, and others. In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.